Enzychem Lifesciences Revenue

In the year 2025, Enzychem Lifesciences had annual revenue of 67.75B KRW, down -12.44%. Enzychem Lifesciences had revenue of 14.10B in the quarter ending December 31, 2025, a decrease of -23.87%.

Revenue

67.75B

Revenue Growth

-12.44%

P/S Ratio

1.13

Revenue / Employee

521.16M

Employees

130

Market Cap

76.86B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.75B	-9.63B	-12.44%
Dec 31, 2024	77.38B	1.34B	1.76%
Dec 31, 2023	76.04B	49.40B	185.46%
Dec 31, 2022	26.64B	3.66B	15.94%
Dec 31, 2021	22.98B	-2.84B	-11.01%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Yuyu Pharma	140.88B
Kukje Pharma	175.50B
MYUNGMOON Pharm co.,Ltd	195.25B
CKD Bio	159.93B
Ildong Holdings	590.89B
Aprogen Biologics	73.23B
HANDOK	535.14B
Jeil Pharma Holdings	657.61B

Revenue Rankings